Free tool
FAERS Monitor: Viracept
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020779 or its brand name (Viracept, Nelfinavir Mesylate). Reports on generic versions are filed under their own applications.
Reports
2,091
Serious
1,922
92% of reports
Hospitalization
674
Death reported
110
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug exposure during pregnancy414
- pain243
- anxiety236
- emotional distress236
- anhedonia210
- foetal exposure during pregnancy203
- chronic kidney disease140
- osteoporosis137
- anaemia120
- bone density decreased115
- premature baby115
- depression110
- renal failure100
- pregnancy96
- osteopenia91
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 194 |
| 2005 | 209 |
| 2006 | 199 |
| 2007 | 161 |
| 2008 | 83 |
| 2009 | 93 |
| 2010 | 209 |
| 2011 | 101 |
| 2012 | 51 |
| 2013 | 29 |
| 2014 | 31 |
| 2015 | 95 |
| 2016 | 91 |
| 2017 | 29 |
| 2018 | 46 |
| 2019 | 130 |
| 2020 | 145 |
| 2021 | 105 |
| 2022 | 42 |
| 2023 | 19 |
| 2024 | 1 |
| 2025 | 8 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,068 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug exposure during pregnancySignal | 414 | 124.0 | 113.6 | 49,838 |
| anhedoniaSignal | 210 | 81.0 | 71.2 | 16,405 |
| osteopeniaSignal | 91 | 60.7 | 49.6 | 5,254 |
| pregnancySignal | 96 | 48.5 | 39.8 | 4,398 |
| premature babySignal | 115 | 38.6 | 32.3 | 4,162 |
| bone density decreasedSignal | 115 | 37.1 | 31.0 | 3,989 |
| osteoporosisSignal | 137 | 33.6 | 28.6 | 4,297 |
| foetal exposure during pregnancySignal | 203 | 25.2 | 22.1 | 4,696 |
| emotional distressSignal | 236 | 19.6 | 17.4 | 4,173 |
| chronic kidney diseaseSignal | 140 | 18.6 | 15.8 | 2,313 |
| anxietySignal | 236 | 8.3 | 7.4 | 1,538 |
| renal failureSignal | 100 | 7.6 | 6.3 | 568 |
| anaemiaSignal | 120 | 6.3 | 5.3 | 538 |
| depressionSignal | 110 | 4.9 | 4.1 | 337 |
| painSignal | 243 | 4.0 | 3.5 | 555 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.